Ziegler Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $761K | Buy |
29,943
+1,526
| +5% | +$38.8K | 0.03% | 312 |
|
|
2023
Q4 | $644K | Hold |
28,417
| – | – | 0.03% | 333 |
|
|
2023
Q3 | $529K | Sell |
28,417
-176
| -0.6% | -$3.28K | 0.02% | 342 |
|
|
2023
Q2 | $743K | Buy |
28,593
+9,860
| +53% | +$256K | 0.03% | 311 |
|
|
2023
Q1 | $538K | Buy |
18,733
+184
| +1% | +$5.28K | 0.02% | 347 |
|
|
2022
Q4 | $549K | Sell |
18,549
-5,051
| -21% | -$150K | 0.02% | 344 |
|
|
2022
Q3 | $562K | Sell |
23,600
-134
| -0.6% | -$3.19K | 0.02% | 341 |
|
|
2022
Q2 | $530K | Buy |
23,734
+10,079
| +74% | +$225K | 0.02% | 346 |
|
|
2022
Q1 | $343K | Sell |
13,655
-1,900
| -12% | -$47.7K | 0.01% | 347 |
|
|
2021
Q4 | $557K | Sell |
15,555
-2,761
| -15% | -$98.9K | 0.02% | 366 |
|
|
2021
Q3 | $780K | Sell |
18,316
-664
| -3% | -$28.3K | 0.03% | 351 |
|
|
2021
Q2 | $822K | Sell |
18,980
-568
| -3% | -$24.6K | 0.03% | 352 |
|
|
2021
Q1 | $797K | Sell |
19,548
-516
| -3% | -$21K | 0.03% | 355 |
|
|
2020
Q4 | $908K | Buy |
20,064
+4,629
| +30% | +$209K | 0.03% | 328 |
|
|
2020
Q3 | $546K | Sell |
15,435
-13,462
| -47% | -$476K | 0.02% | 366 |
|
|
2020
Q2 | $1.09M | Buy |
28,897
+4,047
| +16% | +$153K | 0.03% | 294 |
|
|
2020
Q1 | $718K | Buy |
+24,850
| New | +$718K | 0.02% | 413 |
|